Literature DB >> 16547120

Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.

Yoshiaki Nishioka, Yoshio Horita, Masato Tadokoro, Koichi Taura, Naofumi Suyama, Masanobu Miyazaki, Takashi Harada, Shigeru Kohno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16547120     DOI： 10.1093/ndt/gfl108

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases.

Authors:  Tetsu Akimoto; Toshiya Otake; Akira Tanaka; Hideaki Takahashi; Toshihiko Higashizawa; Makoto Inoue; Katsuhiko Nishino; Osamu Saito; Norio Isoda; Shigeaki Muto; Kentaro Sugano; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2010-12-18       Impact factor: 2.801

2.  Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.

Authors:  Takao Saito; Masayuki Iwano; Koichi Matsumoto; Tetsuya Mitarai; Hitoshi Yokoyama; Noriaki Yorioka; Shinichi Nishi; Ashio Yoshimura; Hiroshi Sato; Satoru Ogahara; Yoshie Sasatomi; Yasufumi Kataoka; Shiro Ueda; Akio Koyama; Shoichi Maruyama; Masaomi Nangaku; Enyu Imai; Seiichi Matsuo; Yasuhiko Tomino
Journal:  Clin Exp Nephrol       Date:  2016-10-25       Impact factor: 2.801
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.